The AIRWAYS-2 primary outcome paper has been published today in the Journal of the American Medical Association (JAMA).
The headline is that the trial found no significant difference between tracheal intubation and the i-gel supraglottic airway device (SGA) in functional outcome at hospital discharge or 30 days after an out of hospital cardiac arrest in adults. However, some differences were noted in the secondary and pre-specified sensitivity analyses that favoured the i-gel. There is much of interest in this finding and the other reported outcomes. Longer-term and economic outcomes will be reported in due course.
Publication is being supported by the release of information in many forms and across many platforms. If you have any queries, feel free to get in touch.
I would like to take this opportunity to thank you for the contribution made by your Trust to the AIRWAYS-2 trial.